IBB
OSUR: More long term picksThis one is one of Tim West's findings. After exhaustive technical analysis on my part, I noticed we had a great chance to enter right at the start of a quarterly rally in the stock, so I took the plunge recently, ahead of earnings, at 8.87. I reduced my position to 3%, down from 13% to book some profit and in case we get a dip to add back to longs. I did swap some of it for other positions, to improve my portfolio, so, it's all good. Naturally, Tim's stock picking prowess once again shined here.
The chart here is really constructive, and you could jump in here, on any setback, or even on a breakout of the earning day high perhaps. I'd reccomend entering a position gradually, if you're interested in riding the long term advance to $24. Buy each day for 2 weeks to a month, until you complete your desired exposure to the stock. Size is up to you and your preferred risk parameters.
Good luck,
Ivan Labrie.
Gilead- ShortCurrent Support: 69-70
Near-Term support: 63
I like Gilead for fundo reasons (massive FCF) but the market is correctly worried about declining hep c revenues and the lack of a transformative acquisition. The trend is clearly down with regards to price, MACD, and RSI. RSI trend-line needs to reverse in order for price to appreciate in my view.
Survey - What would you do in this scenario This is a chart that I sent to my members today.
It presents two potential trades on IBB:
1. Bullish (short term) setup - 270$ is the key zone as it presents a weekly support zone.
2. Bearish continuation (based on longer term analysis) - Continuation of the the waterfall that started on May 2015.
Waiting to here your thoughts.
Biotech (IBB) - trade of the yearIBB is at multi-year cross roads. Ideal for straddles / strangles. A dropping RSI points to a weekly downtrend.
Both trade ideas are plotted. From a fundamental perspective, I believe @realdonaldtrump is right, biotech is getting away with murder. I get one of my meds from overseas because it's 1/182 the cost. Yes, you read it right. It costs me $1 there and $182 here for 10 pills.
North America has one of the most affordable:
1. housing, 2. food, 3. cars, 4. Gas, 5. tech, 6. Financial Markets anywhere in the world. But what is charged for healthcare is OUTRAGEOUS. An open heart surgery done in India, China, Malaysia, Singapore, Russia costs $50,000 including business class airfare and 5 star accommodations ($20,000 is surgery cost) . In USA it is $250,000.
This is a topic that Dems and Republicans are aligned on, it's very important for the most powerful country in the world to have affordable health care and thereby provide capability for it's citizens to live a happy meaningful life.
Reducing healthcare costs should also increase profits for S&P by about 10% within the next 3 years as it's one of the major expense for any company.
JUNO rounding.JPM conference presentation this week. If it's good, or if $KITE is good, this will move.
IBB: Previous year's darling index. IBB has been one of those indexes that has been very easy to trade with, but "blink and you'll miss it" kinda deal. It's been a rough ride for the year, and if the chart is any indication, it's about to get tougher for this index (and its components) soon. No where but down.